WELCOME TO OUR PARKINSON'S PLACE!

I HAVE PARKINSON'S DISEASES AND THOUGHT IT WOULD BE NICE TO HAVE A PLACE WHERE THE CONTENTS OF UPDATED NEWS IS FOUND IN ONE PLACE. THAT IS WHY I BEGAN THIS BLOG.

I COPY NEWS ARTICLES PERTAINING TO RESEARCH, NEWS AND INFORMATION FOR PARKINSON'S DISEASE, DEMENTIA, THE BRAIN, DEPRESSION AND PARKINSON'S WITH DYSTONIA. I ALSO POST ABOUT FUNDRAISING FOR PARKINSON'S DISEASE AND EVENTS. I TRY TO BE UP-TO-DATE AS POSSIBLE.

I AM NOT RESPONSIBLE FOR IT'S CONTENTS. I AM JUST A COPIER OF INFORMATION SEARCHED ON THE COMPUTER. PLEASE UNDERSTAND THE COPIES ARE JUST THAT, COPIES AND AT TIMES, I AM UNABLE TO ENLARGE THE WORDING OR KEEP IT UNIFORMED AS I WISH. IT IS IMPORTANT TO UNDERSTAND I AM A PERSON WITH PARKINSON'S DISEASE. I HAVE NO MEDICAL EDUCATION,

I JUST WANT TO SHARE WITH YOU WHAT I READ ON THE INTERNET. IT IS UP TO YOU TO DECIDE WHETHER TO READ IT AND TALK IT OVER WITH YOUR DOCTOR. I AM JUST THE COPIER OF DOCUMENTS FROM THE COMPUTER. I DO NOT HAVE PROOF OF FACT OR FICTION OF THE ARTICLE. I ALSO TRY TO PLACE A LINK AT THE BOTTOM OF EACH ARTICLE TO SHOW WHERE I RECEIVED THE INFORMATION SO THAT YOU MAY WANT TO VISIT THEIR SITE.

THIS IS FOR YOU TO READ AND TO ALWAYS KEEP AN OPEN MIND.

PLEASE DISCUSS THIS WITH YOUR DOCTOR, SHOULD YOU HAVE ANY QUESTIONS, OR CONCERNS. NEVER DO ANYTHING WITHOUT TALKING TO YOUR DOCTOR FIRST..

I DO NOT MAKE ANY MONEY FROM THIS WEBSITE. I VOLUNTEER MY TIME TO HELP ALL OF US TO BE INFORMED.

I WILL NOT ACCEPT ANY ADVERTISEMENT OR HEALING POWERS, HEALING FROM HERBS AND ETC. UNLESS IT HAS GONE THROUGH TRIALS AND APPROVED BY FDA. IT WILL GO INTO SPAM.

THIS IS A FREE SITE FOR ALL WITH NO ADVERTISEMENTS

THANK YOU FOR VISITING! TOGETHER WE CAN MAKE A DIFFERENCE!

TRANSLATE

Tuesday, December 18, 2018

Growing a brain: Two-step control mechanism identified in mouse stem cells

December 17, 2018, University of Tokyo

This fluorescent microscopy image shows embryonic mouse neurons (green), astrocytes (red), and cell nuclei (blue). University of Tokyo researchers in the lab of Professor Yukiko Gotoh study the differentiation and development of neural stem cells. Their most recent research publication (DOI: 10.1016/j.devcel.2018.11.018) identifies different control mechanisms for the polycomb repressive complex 1 protein at different stages of development. Credit: Gotoh Laboratory of Molecular Biology CC-BY.



Scientists have identified two distinct control mechanisms in the developmental transition of undifferentiated stem cells into healthy brain cells. This fundamental research using mice may inform regenerative medicine treatments for neurodegenerative diseases and spinal cord injuries, in the future.

When an embryo develops, stem cells differentiate into all the types of cells that the adult will need. Neural stem cells differentiate first into neurons, or nerve cells, and then into astrocytes—support cells in the brain. Neural stem cells lose their potential to produce neurons as the embryo matures.

Professor Yukiko Gotoh at the University of Tokyo leads the team of scientists who identified the epigenetic control mechanisms of how neural stem cells lose the potential to produce neurons.

"It is a paradox for regenerative medicine that neural stem cells produce fewer cells as they differentiate into additional cell types. We would like to grow specific cell types and lots of them," said Gotoh.

All body cells have the same DNA, but different genes are turned on or off to make different cell types. To understand brain development, researchers examined how a protein called polycomb repressive complex 1 (PRC1) controls the expression of genes related to neuronal function inside neural stem cells. Earlier results had revealed PRC1 regulates gene expression in stem cells, but not the specifics of how and when.

They collected neural stem cells from the brains of mouse embryos that grew inside a mother mouse until the midpoint of the embryonic development period, or 11 days after conception. Then, researchers separated the cells into two groups to grow outside the body for different periods: one group until it reached the early stage of neural development, when neurons are formed, and the other group until the late stage when the cells turn into astrocytes.

"Neural stem cells must keep track of their own calendar. Even while growing outside the body they differentiate normally into neurons and then into astrocytes," said Gotoh.
Researchers discovered that PRC1 represses genes related to neuronal function through activity of adding a molecule called ubiquitin during early stages of brain development in which neural stem cells produce neurons. 

Then, at later stages of brain development when stem cells switch to producing astrocytes, the ubiquitin-adding activity becomes unnecessary. PRC1 instead becomes clusters (polymers) on these genes in the late stage.

PRC1 represses genes related to neuronal function transiently in the early stage, but permanently in the late stageof brain development.

Understanding the different control mechanisms at two distinct stages of brain development may provide researchers with new tools to manipulate neural stem cells. The results may also help develop methods to change a cell's type: for example, collecting astrocytes out of adult patients and turning those cells into new neurons.

Understanding how the brain first develops different cell types helps researchers imagine how to design treatments for neurodegenerative conditions, such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease), when those cells are damaged. Scientists could also use the same information to treat neuron damage elsewhere in the body, including spinal cord injuries and other ailments.

More information:Yusuke Kishi et al. Regulation of Chromatin Structure During Neural Development, Frontiers in Neuroscience(2018). DOI: 10.3389/fnins.2018.00874

Journal reference: Frontiers in Neuroscience

Provided by: University of Tokyo

https://medicalxpress.com/news/2018-12-brain-two-step-mechanism-mouse-stem.html

No comments:

Post a Comment